Intervention with 7,8-dihydroxyflavone blocks further striatal terminal loss and restores motor deficits in a progressive mouse model of Parkinson's disease. [electronic resource]
- Neuroscience Apr 2015
- 454-71 p. digital
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
1873-7544
10.1016/j.neuroscience.2014.12.080 doi
Animals Antiparkinson Agents--pharmacology Calcium-Binding Proteins Corpus Striatum--drug effects Flavones--pharmacology Forelimb--drug effects Intracellular Signaling Peptides and Proteins--metabolism MPTP Poisoning--drug therapy Male Mice, Inbred C57BL Mitogen-Activated Protein Kinase 1--metabolism Mitogen-Activated Protein Kinase 3--metabolism Motor Activity--drug effects Phosphorylation--drug effects Random Allocation Receptor, trkB--metabolism Stathmin Substantia Nigra--drug effects Tyrosine 3-Monooxygenase--metabolism